These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33937050)

  • 41. Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma.
    Wang Z; Li X; Chen H; Han L; Ji X; Wang Q; Wei L; Miao Y; Wang J; Mao J; Zhang Z
    Med Sci Monit; 2021 May; 27():e929333. PubMed ID: 33979320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis.
    Ye G; Liu Y; Huang L; Zhang C; Sheng Y; Wu B; Wu C; Qi Y
    Ann Transl Med; 2021 Aug; 9(16):1298. PubMed ID: 34532435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway.
    Wu Y; Lin Y; Pan J; Tu X; Xu Y; Li H; Chen Y
    Cancer Cell Int; 2021 Aug; 21(1):443. PubMed ID: 34419073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
    Shi Y; Li Y; Yan C; Su H; Ying K
    Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification key genes, key miRNAs and key transcription factors of lung adenocarcinoma.
    Li J; Li Z; Zhao S; Song Y; Si L; Wang X
    J Thorac Dis; 2020 May; 12(5):1917-1933. PubMed ID: 32642095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
    Gao L; Zhang L
    BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma.
    Li J; Li Q; Su Z; Sun Q; Zhao Y; Feng T; Jiang J; Zhang F; Ma H
    Lipids Health Dis; 2020 Oct; 19(1):222. PubMed ID: 33050938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma.
    Cai W; Jing M; Wen J; Guo H; Xue Z
    Front Genet; 2022; 13():817552. PubMed ID: 35711943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma.
    Li J; Li J; Hao H; Lu F; Wang J; Ma M; Jia B; Zhuo M; Wang J; Chi Y; Zhai X; Wang Y; Wu M; An T; Zhao J; Yang F; Wang Z
    BMC Cancer; 2023 Jan; 23(1):110. PubMed ID: 36721112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrated analysis reveals key genes with prognostic value in lung adenocarcinoma.
    Song YJ; Tan J; Gao XH; Wang LX
    Cancer Manag Res; 2018; 10():6097-6108. PubMed ID: 30538558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
    Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
    Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Key genes involved with prognosis were identified in lung adenocarcinoma by integrated bioinformatics analysis.
    Song H; Wu J; Liu W; Cai K; Xie Z; Liu Y; Huang J; Gan S; Xiong Y; Sun Y
    Heliyon; 2023 Jun; 9(6):e16789. PubMed ID: 37313154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Med Oncol; 2019 Jul; 36(9):73. PubMed ID: 31321566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
    Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
    J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioinformatics-based screening of key genes for transformation of tyrosine kinase inhibitor-resistant lung adenocarcinoma to small cell lung cancer.
    Zhang Y; Chen Q; Huang T; Zhu D; Lu Y
    Front Med (Lausanne); 2023; 10():1203461. PubMed ID: 37583423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of key protein-coding genes in lung adenocarcinomas based on bioinformatic analysis.
    Yao R; Chen X; Wang L; Wang Y; Chi S; Li N; Tian X; Li N; Liu J
    Transl Cancer Res; 2019 Dec; 8(8):2829-2840. PubMed ID: 35117040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.